Literature DB >> 16142560

Population standards of prostate specific antigen values in men over 40: community based study in Turkey.

Talha Müezzinoğlu1, Murat Lekili, Erhan Eser, Bekir S Uyanik, Coşkun Büyüksu.   

Abstract

OBJECTIVE: To determine the prostate specific antigen (PSA) population standards of a cluster of Turkish men with no clinical evidence of prostate cancer. PATIENTS AND METHODS: We evaluated PSA values of the men who were living in a well-defined, rural district of Western Anatolia. Two hundred fifty-seven men agreed to participate in this population-based study. They underwent clinical examination, transrectal ultrasonography and serum PSA measurement. The association between serum PSA and age, prostate volume and age, PSA and prostate volume, and PSA density (PSAD) and age were assessed. Distributions of serum PSA levels, prostate volumes (PV), and PSAD values as a function of age were generated.
RESULTS: The upper limit of normal PSA concentration were 4.51 ng/ml for men aged 40-49 years, 4.36 ng/ml for 50-59 years, 6.17 ng/ml for 60-69 years, and 10.18 ng/ml for over 70 years. The upper limit of normal (95th percentile) for the serum PSA concentration increased with age. Across the entire age range, no correlation was found between the serum PSA concentrations and age while significant correlation was found between serum PSA concentration and prostate volume.
CONCLUSION: In this present study, the PSA values in different age intervals showed higher than those observed in previous studies. The PSA values are mainly affected by prostate volume rather than age.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16142560     DOI: 10.1007/s11255-004-7976-y

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  13 in total

1.  Longitudinal prostate growth rates during 5 years in randomly selected community men 40 to 79 years old.

Authors:  T Rhodes; C J Girman; S J Jacobsen; R O Roberts; H A Guess; M M Lieber
Journal:  J Urol       Date:  1999-04       Impact factor: 7.450

2.  Standardized assessment to enhance the diagnostic value of prostate volume; Part II: Correlation with prostate-specific antigen levels.

Authors:  R G Aarnink; J J de la Rosette; A L Huynen; R J Giesen; F M Debruyne; H Wijkstra
Journal:  Prostate       Date:  1996-11       Impact factor: 4.104

3.  Prostate-specific antigen and prostate gland volume: correlation and clinical application.

Authors:  R J Babaian; H A Fritsche; R B Evans
Journal:  J Clin Lab Anal       Date:  1990       Impact factor: 2.352

4.  The value of percent free prostate specific antigen, prostate specific antigen density of the whole prostate and of the transition zone in Turkish men.

Authors:  B Akduman; T Alkibay; A Tuncel; I Bozkirli
Journal:  Can J Urol       Date:  2000-10       Impact factor: 1.344

5.  Relationship between prostate specific antigen, prostate volume and age in the benign prostate.

Authors:  G N Collins; R J Lee; G B McKelvie; A C Rogers; M Hehir
Journal:  Br J Urol       Date:  1993-04

6.  Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.

Authors:  J E Oesterling; S J Jacobsen; C G Chute; H A Guess; C J Girman; L A Panser; M M Lieber
Journal:  JAMA       Date:  1993-08-18       Impact factor: 56.272

7.  Prostate specific antigen levels in men older than 50 years without clinical evidence of prostatic carcinoma.

Authors:  B L Dalkin; F R Ahmann; J B Kopp
Journal:  J Urol       Date:  1993-12       Impact factor: 7.450

8.  Screening for prostatic carcinoma with prostate specific antigen.

Authors:  M K Brawer; M P Chetner; J Beatie; D M Buchner; R L Vessella; P H Lange
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

9.  The distribution of prostate specific antigen in men without clinical or pathological evidence of prostate cancer: relationship to gland volume and age.

Authors:  R J Babaian; H Miyashita; R B Evans; E I Ramirez
Journal:  J Urol       Date:  1992-03       Impact factor: 7.450

10.  Serum prostate-specific antigen in a community-based population of healthy Japanese men: lower values than for similarly aged white men.

Authors:  J E Oesterling; Y Kumamoto; T Tsukamoto; C J Girman; H A Guess; N Masumori; S J Jacobsen; M M Lieber
Journal:  Br J Urol       Date:  1995-03
View more
  4 in total

1.  Age-Specific Reference Ranges of Prostate-Specific Antigen among Saudi Men as a Representation of the Arab Population.

Authors:  Danny Munther Rabah; Karim Hamda Farhat; Mohamed Abdullah Al-Atawi; Mostafa Ahmed Arafa
Journal:  Med Princ Pract       Date:  2019-02-07       Impact factor: 1.927

2.  Differences in prostate cancer detection between Canadian and Saudi populations.

Authors:  O Z Al-Abdin; D M Rabah; G Badr; A Kotb; A Aprikian
Journal:  Braz J Med Biol Res       Date:  2013-06-25       Impact factor: 2.590

3.  On the information hidden in a classifier distribution.

Authors:  Farrokh Habibzadeh; Parham Habibzadeh; Mahboobeh Yadollahie; Hooman Roozbehi
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

4.  A hospital based study on reference range of serum prostate specific antigen levels.

Authors:  Aditi Gupta; Deepa Gupta; Arun Raizada; Narmada Prasad Gupta; Rajiv Yadav; Kamini Vinayak; Vijay Tewari
Journal:  Indian J Med Res       Date:  2014-10       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.